Fertility Docs Uncensored

What does a realistic IVF journey actually look like—and how do you know when to keep going, pause, or consider a different path? In this episode, Dr. Susan Hudson and Dr. Carrie Bedient take a candid look at the realities of fertility treatment, from understanding IVF success rates to interpreting what happens during an individual cycle. They explore why statistics don’t tell the whole story, what factors can shape a patient’s prognosis, and the moments when it may be worth stepping back and reassessing the plan. But fertility treatment isn’t just about numbers and test results. The conversation also addresses the emotional toll of IVF, the importance of having the right support system, and how asking better questions—or getting a second opinion—can help patients feel more informed and confident in their decisions. Whether you’re considering IVF, in the middle of treatment, or trying to understand what comes next, this episode offers an honest and reassuring conversation about navigating the medical, emotional, and deeply personal decisions that come with a fertility journey.

In this listener Q&A episode, Dr. Susan Hudson from Texas Fertility Center and Dr. Carrie Bedient from Fertility Center of Las Vegas breakdown the real information patients need to know. We’re tackling some of your biggest questions about fertility testing—from BV, HPV, AMH, and sperm counts to PGT-A, failed FETs, tubal issues, and when it may be time to consider IVF. We break down what the evidence actually tells us, which tests may be worth considering, and when additional testing is unlikely to change the next step. Plus, we discuss fertility testing in early pregnancy and share practical guidance for navigating the often-confusing world of fertility workups. Tune in for real answers from real patients going through their fertility journeys!

In this episode, Dr. Susan Hudson and Dr. Carrie Bedient sit down with Maria Katz, a genetic counselor at Orchid Health, to explore the rapidly evolving world of whole genome sequencing for embryos. Maria details what genetic counselors do in fertility care, how their role differs from that of medical geneticists, and the specialized training that prepares them to help patients navigate complex genetic information. The conversation answers common questions about embryo testing, common acronyms, and how to select the right testing platform. Whether you’re a fertility professional, a patient considering embryo testing, or simply interested in the intersection of genetics and reproductive medicine, this episode offers an accessible look at the opportunities and complexities of sequencing an embryo’s genome.

In this episode, Dr. Carrie Bedient and Dr. Susan Hudson are joined by special guest Dr. Stephanie Brownridge to explore the latest insights into polycystic ovarian syndrome (PCOS) and the proposed shift to polycystic ovarian metabolic syndrome (PMOS). They discuss why the name change matters, how the condition extends beyond the ovaries, and what it means for diagnosis, fertility, and long-term health. The conversation covers the difference between ovarian cysts and follicles, the roles of insulin resistance and hormonal imbalance, current treatment options including letrozole, metformin, and emerging GLP-1 receptor agonists, as well as the value of a multidisciplinary approach to care. The doctors also address pregnancy risks, lifestyle and nutrition strategies, and how PMOS is diagnosed across a broad spectrum of symptoms. Whether you've been diagnosed with PCOS, are trying to conceive, or simply want to better understand this common condition, this episode offers practical, evidence-based guidance to help you navigate reproductive and metabolic health.

In this episode, join Dr. Carrie Bedient from Fertility Center of Las Vegas and Dr. Susan Hudson from Texas Fertility Center as they explore the evolving role of Preimplantation Genetic Testing for Aneuploidy (PGT-A) in improving IVF outcomes and helping patients make more informed decisions on their fertility journey. The docs discuss how PGT-A is used to identify embryos with the highest potential for implantation, the science behind embryo genetic testing, and the complexities of interpreting mosaic embryo results. The conversation also examines the fascinating and often debated field of reproductive immunology, highlighting what current research tells us about the immune system's role in fertility and where evidence is still emerging. They break down the risks and benefits of PGT-A across different age groups, why it may be particularly valuable for women over 35 or those with recurrent pregnancy loss, and the ethical considerations surrounding embryo selection and transfer.